This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 36625057 Submitted by lobbyist on: February 15, 2018 03:04:21 PM Accepted by Registrar on: February 15, 2018 03:15:51 PM
Lobbyist Information
Gale, Keltie
655 Bay Street, Suite 401
Toronto, ON, M5G 2K4
647-776-8010
Canada
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
Santis Health Inc.
655 Bay Street, Suite 401
Toronto, ON, M5G 2K4
647-776-8010
Canada
Client Information
Amgen Canada
Amgen is one of the world's leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.
6775 Financial Drive Suite 100
Mississauga, ON, L5N 0A4
416-399-5864
Canada
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
February 5, 2018
December 31, 2018
Other Individuals Engaged to Lobby
Wallace, Ross
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
Amgen Canada has engaged Santis to communicate with policy makers about how Canada can ensure it captures the full benefit of biosimilar medications used in oncology. Biosimilars are new medications approved by Health Canada. Biosimilars for oncology specifically are not yet on the Canadian market but policy makers will need to be prepared for medications that will likely be coming to market soon.
